Molecular Differences Between Pediatric & Adult Psoriasis Plaques
Pembrolizumab May Induce Sarcoid-Like Skin Reactions
Dermatology Consults May Cut Hospital Stays, Readmissions
What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities
European Group Offers Guidance on Managing Juvenile Dermatomyositis
U.S. FDA Approves Lilly’s Ixekizumab for Plaque Psoriasis
Plaque Psoriasis: Secukinumab Beats Ustekinumab in a Head-to Head Clinical Trial & Ixekizumab Helps Improve Productivity
Psoriasis Drug Succeeds in Mid-Stage Study
